Plain-English translation of NCT01419561 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study designed to understand KSHV inflammatory cytokine syndrome (KICS), a condition caused by a virus that triggers severe inflammation in the body. Researchers want to learn more about how this condition develops, what symptoms it causes, and how it progresses over time. By closely observing patients with KICS, the study aims to build a clearer picture of this newly recognized disease.
KICS is a newly discovered condition that doctors are still learning about. Right now, there is no standard way to diagnose it or treat it. This study exists to help researchers understand the natural course of the disease so that better treatments and diagnostic approaches can be developed in the future.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be evaluated to confirm you have KICS, and then you will be followed over time with regular visits to your doctor. During these visits, researchers will monitor your symptoms, run blood tests, and possibly perform imaging scans to track how your condition changes. The study is primarily observational, meaning researchers are watching and documenting what happens naturally with your condition rather than testing a new drug on you initially.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States